iqvia semaglutide tirzepatide prescriptions us q3 2024 GLP-1 prescription trends through June GLP-1 RA prescription trends: January

BMC Cancer 14 , 985 (2014)

Trust your instinct and do not keep pushing methyl-folate

Patients with a history of gene therapy or hematopoietic stem cell transplantation were excluded.Data were summarized descriptively by genotype, age, and gender

Dai J, Xie Y, Wu Q, et al

Dose Group GI Adverse Events (%) Nausea (%) Abdominal Discomfort/Pain Placebo 32.6% 11.6% Low baseline 1 mg 48.6% ~20% Mild, infrequent 4 mg (escalated) 60.0% ~30% Moderate increase 8 mg (escalated) 57.5% ~38% Present in dose-escalation phase 12 mg (escalated) 66.7% 45.8% Highest incidence, mostly transient Source: Jastreboff AM, Kaplan LM, Fras JP, et al

Allergen-induced airway remodelling